Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Ariad Pharmaceuticals Inc (ARIA)  
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 185,611,000
Market Cap: N/A
Last Volume: 6,246,627 Avg Vol: 2,897,741
52 Week Range: $23.99 - $23.99
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile  


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-04 2023-11-03 2023-05-05 2022-05-05

   
Records found: 703
  Page 10 of 29  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Bollag Daniel M Sr. VP, Reg. Affairs & Quality   •       •      –    2014-04-01 4 OE $0.00 $0 D/D 6,000 150,463     -
   Clackson Timothy P President, R&D, CSO   •       •      –    2014-04-01 4 OE $0.00 $0 D/D 13,000 409,528     -
   Berstein David L SVP, GC and Chief IP Officer   •       •      –    2014-04-01 4 OE $0.00 $0 D/D 6,000 233,042     -
   Fitzgerald Edward M Executive VP, CFO   •       •      –    2014-04-01 4 D $8.52 $36,108 D/D (4,238) 270,928     -
   Fitzgerald Edward M Executive VP, CFO   •       •      –    2014-04-01 4 OE $0.00 $0 D/D 13,000 275,166     -
   Berger Harvey J MD Chairman & CEO   •       •      –    2014-04-01 4 D $8.52 $115,736 D/D (13,584) 1,129,324     -
   Berger Harvey J MD Chairman & CEO   •       •      –    2014-04-01 4 OE $0.00 $0 D/D 41,667 1,142,908     -
   Clackson Timothy P President, R&D, CSO   •       •      –    2014-03-21 4 AS $7.89 $52,583 D/D (6,667) 394,377     -
   Cantor Maria E SVP, Corporate Affairs and HR   •       •      –    2014-03-21 4 AS $7.89 $28,930 D/D (3,667) 82,379     -
   Haluska Frank SVP, Clinical R&D, CMO   •       •      –    2014-03-21 4 AS $7.89 $18,941 D/D (2,400) 99,196     -
   Berstein David L SVP, GC and Chief IP Officer   •       •      –    2014-03-21 4 AS $7.89 $12,630 D/D (1,600) 227,042     -
   Bollag Daniel M Sr. VP, Reg. Affairs & Quality   •       •      –    2014-03-21 4 AS $7.89 $18,936 D/D (2,400) 144,463     -
   Clackson Timothy P President, R&D, CSO   •       •      –    2014-03-20 4 OE $0.00 $0 D/D 13,333 401,044     -
   Berger Harvey J MD Chairman & CEO   •       •      –    2014-03-20 4 D $8.13 $90,113 D/D (11,084) 1,097,964     -
   Berger Harvey J MD Chairman & CEO   •       •      –    2014-03-20 4 OE $0.00 $0 D/D 34,000 1,109,048     -
   Cantor Maria E SVP, Corporate Affairs and HR   •       •      –    2014-03-20 4 OE $0.00 $0 D/D 7,333 86,046     -
   Haluska Frank SVP, Clinical R&D, CMO   •       •      –    2014-03-20 4 OE $0.00 $0 D/D 6,000 101,596     -
   Berstein David L SVP, GC and Chief IP Officer   •       •      –    2014-03-20 4 OE $0.00 $0 D/D 4,000 228,642     -
   Bollag Daniel M Sr. VP, Reg. Affairs & Quality   •       •      –    2014-03-20 4 OE $0.00 $0 D/D 6,000 146,863     -
   Fitzgerald Edward M Executive VP, CFO   •       •      –    2014-03-20 4 D $8.13 $22,089 D/D (2,717) 261,556     -
   Fitzgerald Edward M Executive VP, CFO   •       •      –    2014-03-20 4 OE $0.00 $0 D/D 8,333 264,273     -
   Duvall Martin J EVP, CCO   •       •      –    2014-03-20 4 D $8.13 $4,301 D/D (529) 30,340     -
   Duvall Martin J EVP, CCO   •       •      –    2014-03-20 4 OE $0.00 $0 D/D 1,666 30,869     -
   Clackson Timothy P President, R&D, CSO   •       •      –    2014-03-19 4 D $8.19 $28,190 D/D (3,442) 387,711     -
   Clackson Timothy P President, R&D, CSO   •       •      –    2014-03-19 4 OE $0.00 $0 D/D 10,834 391,153     -
  703 Records found
  Previous  10  11  12  13  14  15  16  17  18  19  Next   
  Page 10 of 29
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us